Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Phase 2 data showed weight loss around 24% at 48 weeks, but retatrutide is still earlier in development
"So they go to other providers and some of these providers unfortunately do not provide medication that has gone through the right channels
But they are not universal solutions, and their long-term safety, sustainability and accessibility remain unresolved
The phase 2 trial showed 22.8% average weight loss at 48 weeks with the 8mg dose, only 1.4 percentage points less than the 12mg dose
Both platforms serve patients seeking convenience, but their clinical intake processes, medication formulations, and support models differ meaningfully
US$ 20.15
US$ 26.80
US$ 27.58
US$ 28.39
US$ 26.20
